Introduction of Institute of Alzheimer disease
The major research directions of the Institute of Alzheimer disease are (i) epidemiologic study on Alzheimer disease; (ii) genomics research on Alzheimer disease; (iii) peripheral biomarkers research on Alzheimer disease; (iv) neuropsychological study on Alzheimer disease; (v) neuroimaging research on Alzheimer disease; (vi) clinical trial research on Alzheimer disease; (vii) database construction and data analysis. The Institute of Alzheimer disease consists of 7 research offices, which are Alzheimer disease Epidemiological Research Office, Alzheimer disease Genomics Research Office, Alzheimer disease Peripheral Biomarkers Research Office, Alzheimer disease Neuropsychological Research Office, Alzheimer disease Neuroimaging Research Office, Alzheimer disease Clinical Trial Research Office and Database Construction and Data Analysis Office. There are 19 PIs in the Institute of Alzheimer disease.
Jia Jianping, M.D, Ph.D
Neurologist and Professor
Director of Center for Neurological disorders, Beijing Friendship Hospital, Beijing, China
Dr. Lin Li is the deputy director of Alzheimer’s Disease Institute, Beijing Institute of Brain Research;
Professor, State Key Laboratory of Brain and Cognitive Science
Institute of Biophysics, Chinese Academy of Sciences.
Chang Chen, Ph.D., Professor, Principal Investigator at the Institute of Biophysics, Chinese Academy of Sciences.
Chief physician, Department of Neurology of Xuanwu Hospital affiliated to Capital Medical University
Ying HAN, M.D., Ph.D.
Professor and Supervisor for doctor candidates
Chief Physician, in the Department of Neurology, XuanWu Hospital of Capital Medical University
Dept. of Radiology, Xuan Wu Hospital, Capital Medical University
Ji-Hui Lu, MD
Director, Department of Old Age Psychiatry, Beijing Geriatric Hospital, Beijing, China
